Loading...
Protein S deficiency challenges venous thromboembolism (VTE) management. Guidelines discourage routine protein S testing in patients requiring lifelong anticoagulation or with unprovoked/recurrent VTE. Questions persist about the role of genetics in these patients. This large-scale (>600,000 individuals), population-based multiomic study from U.K and U.S. datasets clarifies the prevalence of PROS1 variants and their relationship to circulating protein S levels and thrombosis risk. The researchers used the functional impact score (FIS; range 0–1), which categorizes gene variants based on their evolutionary conservation; higher scores predict more-severe disruption of the protein's function.
The results were as follows:
High-risk PROS1 variants…